BR0010216A - Derivados de tio-oxindol - Google Patents

Derivados de tio-oxindol

Info

Publication number
BR0010216A
BR0010216A BR0010216-4A BR0010216A BR0010216A BR 0010216 A BR0010216 A BR 0010216A BR 0010216 A BR0010216 A BR 0010216A BR 0010216 A BR0010216 A BR 0010216A
Authority
BR
Brazil
Prior art keywords
thio
oxindole derivatives
compounds
progesterone
derivatives
Prior art date
Application number
BR0010216-4A
Other languages
English (en)
Inventor
Andrew Fensome
Juwen Zhang
Jay E Wrobel
Lin Zhi
Todd K Jones
Christopher M Tegley
Marci C Koko
James P Edwards
Edward G Melenski
Original Assignee
American Home Prod
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,033 external-priority patent/US6355648B1/en
Application filed by American Home Prod, Ligand Pharm Inc filed Critical American Home Prod
Publication of BR0010216A publication Critical patent/BR0010216A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

"DERIVADOS DE TIO-OXINDOL". Esta invenção relaciona-se a compostos que são agonistas do receptor de progesterona que possuem estruturas gerais (1) ou (2) em que os substituintes são conforme definidos; ou um sal dele farmaceuticamente aceitável, bem como métodos de utilizar esses compostos para induzir a contracepção ou tratar carcinomas e adenocarcinomas relacionados à progesterona.
BR0010216-4A 1999-05-04 2000-05-01 Derivados de tio-oxindol BR0010216A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17225999P 1999-05-04 1999-05-04
US09/552,033 US6355648B1 (en) 1999-05-04 2000-04-19 Thio-oxindole derivatives
PCT/US2000/011630 WO2000066555A1 (en) 1999-05-04 2000-05-01 Thio-oxindole derivatives

Publications (1)

Publication Number Publication Date
BR0010216A true BR0010216A (pt) 2002-03-19

Family

ID=26867898

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010216-4A BR0010216A (pt) 1999-05-04 2000-05-01 Derivados de tio-oxindol

Country Status (18)

Country Link
EP (1) EP1181275A1 (pt)
JP (1) JP2002543182A (pt)
KR (1) KR20020000636A (pt)
CN (1) CN1143847C (pt)
AU (1) AU767762B2 (pt)
BG (1) BG106078A (pt)
BR (1) BR0010216A (pt)
CA (1) CA2371633A1 (pt)
CZ (1) CZ20013950A3 (pt)
EA (1) EA005034B1 (pt)
GE (1) GEP20043266B (pt)
HU (1) HUP0200993A3 (pt)
MX (1) MXPA01011285A (pt)
NO (1) NO320912B1 (pt)
NZ (1) NZ515351A (pt)
PL (1) PL351407A1 (pt)
SK (1) SK15902001A3 (pt)
TR (1) TR200103288T2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005010065D1 (de) * 2004-04-08 2008-11-13 Wyeth Corp Verfahren zur minimierung von thioamidverunreinigungen
CN100522960C (zh) * 2004-04-08 2009-08-05 惠氏公司 作为黄体酮受体调节剂的硫代酰胺衍生物
GB201113538D0 (en) * 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
CN104995194B (zh) * 2012-10-12 2017-08-29 学校法人冲绳科学技术大学院大学学园 螺环吲哚衍生物及其制备方法
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
EP3519393B1 (en) * 2016-09-30 2022-05-18 Epizyme Inc Substituted fused bi- or tri- heterocyclic compounds as ehmt2 inhibitors

Also Published As

Publication number Publication date
NO20015380D0 (no) 2001-11-02
BG106078A (en) 2002-05-31
NO320912B1 (no) 2006-02-13
JP2002543182A (ja) 2002-12-17
KR20020000636A (ko) 2002-01-05
NZ515351A (en) 2004-01-30
EA200101180A1 (ru) 2002-04-25
MXPA01011285A (es) 2003-09-04
HUP0200993A2 (hu) 2002-07-29
CN1349499A (zh) 2002-05-15
PL351407A1 (en) 2003-04-22
EA005034B1 (ru) 2004-10-28
CA2371633A1 (en) 2000-11-09
CN1143847C (zh) 2004-03-31
AU767762B2 (en) 2003-11-20
EP1181275A1 (en) 2002-02-27
GEP20043266B (en) 2004-06-25
SK15902001A3 (sk) 2002-11-06
CZ20013950A3 (cs) 2002-06-12
AU4681400A (en) 2000-11-17
TR200103288T2 (tr) 2002-04-22
NO20015380L (no) 2002-01-03
HUP0200993A3 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
NO20022655D0 (no) <Beta>-2-adrenerge reseptoragonister
BRPI0411699A (pt) compostos para uso como substáncia terapeuticamente ativa; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação de receptores cb1 e uso destes compostos
BR0206985A (pt) Anticorpos modificados e métodos de uso
CY1105144T1 (el) Χρηση μιας ουσιας που συνδεεται στον πepιφepειακο υποδοχεα των βενζοδιαζεπινων στη θepαπεια του δepματικου στρες
BR0213846A (pt) métodos de induzir seletivamente a apoptose nas células alvo que expressam dr5, de inibir a proliferação de células alvo que expressam dr5 e de tratar um paciente tendo uma doença inflamatória ou doença autoimune, e, composição
BR9910832A (pt) Agonistas de receptores "beta" 2-adrenérgicos
BR0009320A (pt) Dibenzopiranos como antagonistas do receptor glicocorticóide para o tratamento da diabete
BR0009814A (pt) Processo para tratar de uma doença associada com o receptor-beta estrogênico
DE69732868D1 (de) Mittel gegen Juckreiz
EE200100243A (et) 5HT1 retseptori agonistid ja metoklopramiid migreeni raviks
ID27820A (id) APLIKASI-APLIKASI PENGOBATAN POLIPEPTIDA MATURE FLINT (mFLINT) ATAU OPG3, BAGIAN KELOMPOK SUPER RESEPTOR TNF
DK1450811T3 (da) Forbindelser specifikke af adenosin A1- og A3-receptorer og anvendelser heraf
DK1019426T3 (da) Hidtil ukendte A1-adenosinreceptoragonister og -antagonister
CY1106726T1 (el) Υποκατεστημενα βενζοπυρανια ως επιλεκτικοι συναγωνιστες οιστρογονικου υποδοχεα β
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
BR9809071A (pt) Agentes farmacológicos
NO20020574L (no) Substituerte 1,5-dihydropyrrol-2-on derivater som er virksomme som NMDA-reseptorantagonister for behandlingen avsmertetilstanden
BR0212329A (pt) Métodos para tratar doença pulmonar
NO20051663L (no) Fremgangsmater for behandling av neurodegenerasjon
BR0015540A (pt) Antagonistas do receptor de adenosina e métodos de preparação e uso dos mesmos
BR0010216A (pt) Derivados de tio-oxindol
CY1106194T1 (el) Θepαπευτικη αγωγη της δυσκινησιας
BR9814867A (pt) Método para tratar discinesias relacionadas a doenças ou induzidas por drogas
ECSP003590A (es) Compuestos calcioliticos
DK0883401T3 (da) AT1-receptorantagonist til stimulering af apoptose

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: LIGAND PHARMACEUTICALS, INC. (US) , WYETH (US)

Free format text: ALTERADO DE: AMERICAN HOME PRODUCTS CORPORATION

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.